← Concept Vault
Concept · Neuroscience · Maps to the Law of Vibration

Norepinephrine

Dopamine gets the headlines for wanting. Norepinephrine is the one that decides whether you're even awake enough to want anything — and how sharply.
Read · 21 minPillar · Neuroscience

Most people who've heard of brain chemicals know dopamine (motivation, reward) and serotonin (mood, the SSRI target). Norepinephrine sits underneath both, less famous and more foundational, because it doesn't carry a single "feeling." It carries a setting — the gain knob on the whole nervous system. It's the molecule of alertness, urgency, and focus under pressure, and it runs the same machinery whether you're dodging a car, locking onto a hard problem, or lying awake at 3 a.m. unable to stop your heart from pounding. The interesting part isn't that it makes you alert. It's that there's a roughly optimal amount of it that makes you sharp — and a little more makes you stupid. That shape — the inverted-U of arousal and performance — is one of the more durable findings in behavioral neuroscience, even if the tidy bell curve gets oversold (we'll cut that down to size later), and almost nobody can name it. Let's pull it down to the molecule and back up to the panic attack.

01

What it is

Norepinephrine (NE) — called noradrenaline in British and most European literature; the two words name the identical molecule — is a catecholamine, the same chemical family as dopamine and epinephrine (adrenaline). All three are built on the same backbone, a benzene ring with two hydroxyl groups (the "catechol") attached to an amine. They're not separate inventions; they're a short assembly line. The body makes them in sequence:

Tyrosine → L-DOPA → Dopamine → Norepinephrine → Epinephrine.

That's worth sitting with. Dopamine is one enzymatic step away from norepinephrine — the enzyme dopamine β-hydroxylase adds a single hydroxyl group and converts the molecule of wanting into the molecule of alarm. And norepinephrine is one further step (a methyl group, added by the enzyme PNMT) from epinephrine. They are chemical neighbors, which is exactly why their effects overlap and why people confuse them.

Here is the distinction that clears up most of the confusion, and it's the most important structural fact in this entire dive:

*Norepinephrine is primarily a neurotransmitter — a brain signal. Epinephrine (adrenaline) is primarily a hormone — a bloodstream signal.*

  • Norepinephrine is released by neurons, in the brain and at the endings of the sympathetic nervous system throughout the body. In the brain its source is a tiny structure called the locus coeruleus (more on that — it's the heart of this dive). In the body, sympathetic nerve endings squirt NE directly onto the heart, blood vessels, and organs.
  • Epinephrine is dumped into the blood by the adrenal medulla (the core of the adrenal glands sitting on top of your kidneys) when the sympathetic system fires. It's the systemic broadcast — it floods everywhere at once via circulation, hitting tissues that no nerve directly touches.

So when your heart slams during a near-miss in traffic: the first, fastest jolt is norepinephrine released straight onto your heart muscle by sympathetic nerves (milliseconds). The sustained surge, the shaky-hands-for-ten-minutes-afterward feeling, is largely epinephrine from the adrenal medulla circulating through your blood. Same crisis, two delivery systems, one a telegraph and one a flood. This established division — NE as the neural/local fast signal, epinephrine as the hormonal/systemic broadcast — is textbook physiology, not contested.

02

What it does

Strip it to one sentence: norepinephrine sets arousal and biases the brain toward the urgent.

"Arousal" here is not the sexual sense and not just "awake vs. asleep." It's the technical sense: the overall level of activation and readiness of the nervous system — how primed you are to detect, react, and act. NE is the principal chemical that turns that level up. Its functional jobs, in rough order from body to mind:

  1. Fight-or-flight (the body). Through the sympathetic nervous system, NE raises heart rate and contraction force, constricts most blood vessels (raising blood pressure), dilates the pupils, opens the airways, redirects blood from gut to muscle, and mobilizes glucose. This is the physical hardware of "threat detected, prepare to move." Walter Cannon described and named this whole pattern in the early 20th century (his 1915 book Bodily Changes in Pain, Hunger, Fear and Rage coined "fight or flight").
  1. Wakefulness and the sleep-wake switch. NE neurons in the locus coeruleus fire fastest during alert waking, slow during drowsy/quiet states, slow further in non-REM sleep, and go almost completely silent during REM (dreaming) sleep. This silence is one of the cleanest findings in the field. It means the noradrenergic system is essentially offline while you dream — part of why dreams feel vivid yet you can't reason about how bizarre they are; the alerting, vigilance-tuning system is switched off.
  1. Vigilance and threat detection. NE biases your sensory and attentional systems toward stimuli that might matter — especially novel, salient, or threatening ones. It's why a sudden noise snaps your head around before you've consciously decided anything.
  1. Attention and focus. This is the cognitive payoff and the part most relevant to performance, ADHD, and the stimulant story. The right amount of NE sharpens signal over noise in the prefrontal cortex — the part of the brain that holds a goal in mind and ignores distraction. Too little and you can't hold focus; too much and focus shatters into anxious scanning.
  1. Memory consolidation. Emotionally arousing events are remembered better, and NE is a major reason. The amygdala, drenched in NE during emotional arousal, tags an experience as "important — save this." This is why you remember exactly where you were during a shock or trauma and forget a thousand ordinary Tuesdays. (It's also why beta-blockers, which dampen NE's effects, are being studied to blunt traumatic memory consolidation — more in the frontier section.)

The through-line: *NE doesn't tell you what to do. It tells the rest of the brain how urgently to be running, and which inputs deserve priority.* It's a gain control, not a command.

03

The mechanism

Now the machinery, molecular up to behavioral. This is where it earns the "definitive" label, so we go slow.

Synthesis and storage. Inside a noradrenergic neuron, the assembly line above runs: tyrosine hydroxylase (the rate-limiting, slowest enzyme — it's the bottleneck that controls how much NE you can make) converts tyrosine to L-DOPA; then to dopamine; then dopamine β-hydroxylase finishes the job inside synaptic vesicles, converting dopamine to norepinephrine. Finished NE is packaged in vesicles, waiting at the nerve terminal.

Release. When the neuron fires, calcium rushes in and vesicles fuse with the membrane, dumping NE into the synaptic cleft — or, in the brain, often into the broader extracellular space (NE frequently acts by "volume transmission," diffusing to many neurons at once rather than to a single partner across a tight synapse — fitting for a global gain signal).

Receptors — and this is the crux of the inverted-U. NE acts on adrenergic receptors, of which the brain-relevant families are:

  • Alpha-2 (α2) receptors — high affinity, meaning they respond to low concentrations of NE. In the prefrontal cortex, stimulating postsynaptic α2A receptors strengthens working-memory networks and improves focus. These are the "good arousal" receptors.
  • Alpha-1 (α1) and Beta (β) receptors — lower affinity, meaning they only kick in at higher concentrations of NE. When NE floods (high stress), these engage and impair prefrontal function while strengthening the amygdala and habit circuits.

Hold that, because it's the elegant part. The same molecule has opposite effects at different concentrations because it hits different receptors with different sensitivities. Low-to-moderate NE → α2A engaged → prefrontal cortex tuned up, thinking sharp. High NE → α1 and β flood in → prefrontal cortex shut down, brain handed over to fast, reflexive, emotional circuits. The inverted-U of arousal is built into the receptor pharmacology. Amy Arnsten at Yale spent decades mapping exactly this — her work showing that stress-level catecholamines impair prefrontal function through these receptors is among the best-characterized mechanisms in cognitive neuroscience. This is established, not speculative.

Termination. NE's action ends mostly by reuptake — a transporter protein (NET, the norepinephrine transporter) pulls NE back into the neuron to be reused. Some is broken down by enzymes (monoamine oxidase, MAO; and COMT). NET is the molecular target that ties this whole dive to ADHD medication: block NET and NE lingers in the synapse longer. Atomoxetine (Strattera) does exactly and only this. Stimulants like methylphenidate and amphetamine do it too (and to dopamine's transporter as well).

The source — the locus coeruleus. Here's the anatomical fact that makes NE remarkable. The great majority of the brain's norepinephrine — and essentially all of the supply to the cortex and hippocampus — comes from one tiny, paired nucleus in the brainstem (the pons): the locus coeruleus ("blue spot" — it's pigmented blue-ish from neuromelanin, a byproduct of catecholamine synthesis). (A handful of smaller noradrenergic cell groups in the lateral tegmentum and medulla — the A1/A2/A5/A7 clusters — supply some NE to the hypothalamus, brainstem, and spinal cord, so the LC is the dominant but not the sole noradrenergic source.) It's small — on the order of tens of thousands of neurons in total in humans (published counts vary), a rounding error against the brain's ~86 billion. Yet those relatively few neurons send axons that branch and project to nearly the entire brain — cortex, hippocampus, amygdala, cerebellum, spinal cord (the striatum is a notable exception it largely skips). One small nucleus, near-universal reach. This is the architecture of a broadcast system: when the locus coeruleus changes its firing, it changes the operating state of the whole brain at once. That's how a single tiny structure can flip you from drowsy to laser-focused to panicked.

The locus coeruleus has two firing modes, and the difference between them is the key to modern theory:

  • Tonic firing — a baseline background rate. Low tonic = drowsy/inattentive. Moderate tonic = calm, focused, exploitative attention. High tonic = jittery, distractible, scanning.
  • Phasic firing — sharp bursts locked to important, decision-relevant events. These bursts are thought to "stamp in" the current task and drive focused action.

The relationship between these two modes is the Aston-Jones adaptive-gain theory, which we'll get to — it's the frontier of how this system is understood.

04

The landmark science

Named studies, named people, real dates. This is the spine.

Walter B. Cannon (1910s–1930s) — Harvard physiologist who described the "fight-or-flight" response and the role of the sympatho-adrenal system in mobilizing the body for emergency. He coined "fight or flight" (1915) and later developed "homeostasis" (1926/1932). He didn't isolate norepinephrine — he worked with what he called "sympathin" — but he built the entire conceptual frame the molecule lives in. (Established, foundational.)

Ulf von Euler (1946) — Swedish physiologist who identified noradrenaline as the actual neurotransmitter of sympathetic nerves, correcting the prior assumption that it was adrenaline. This is why the term is "noradrenaline" — nor-adrenaline, the demethylated precursor. He shared the 1970 Nobel Prize in Physiology or Medicine (with Julius Axelrod and Bernard Katz) for discoveries about the humoral transmitters in nerve terminals; his share rested on the noradrenaline work. (Established.)

Julius Axelrod (1950s–60s, Nobel 1970) — worked out how catecholamines are inactivated, especially the reuptake mechanism and the enzyme COMT. Reuptake is the whole reason reuptake-inhibitor drugs exist. Without Axelrod there's no mechanistic basis for atomoxetine or the NE component of stimulants. (Established.)

Robert Yerkes and John Dillingham Dodson (1908) — the oldest and most-cited piece here, and the one most often misquoted. Their original experiment used mice (Japanese dancing mice) learning a black/white visual discrimination under electric-shock motivation. They found that for a difficult discrimination, performance was best at moderate shock intensity and worse at both low and high intensity — while for an easy task, higher intensity kept helping. This produced the famous inverted-U ("Yerkes-Dodson law"): performance rises with arousal up to an optimum, then falls. The critical, usually-forgotten nuance from the original 1908 paper: the optimal arousal level depends on task difficulty — harder tasks have a lower optimal arousal. (Established as a phenomenon; see the honest cut for how it's been distorted.)

Gary Aston-Jones and colleagues (1980s onward) — recorded directly from locus coeruleus neurons in behaving monkeys and rats and discovered the tonic/phasic firing distinction. Their landmark synthesis with Jonathan Cohen, the *Aston-Jones–Cohen adaptive-gain theory (2005, Annual Review of Neuroscience), reframed the locus coeruleus not as a simple "arousal on/off" but as a system that regulates the exploration–exploitation tradeoff*. (Current dominant framework; see frontier.)

Amy Arnsten (1990s–present, Yale) — mapped the receptor basis of the inverted-U in the prefrontal cortex: α2A stimulation improves PFC function at moderate NE; α1/β flooding impairs it at high NE. Her work directly explains why stress makes smart people make dumb decisions and underpins the use of the α2A agonist guanfacine in ADHD. (Established mechanism.)

James McGaugh and Larry Cahill (1990s–2000s) — established that emotional arousal enhances memory consolidation via noradrenergic action in the amygdala, and that blocking it (e.g., with the beta-blocker propranolol) blunts the memory advantage for emotional material — the key human demonstration being Cahill, Prins, Weber & McGaugh, Nature, 1994. This is the empirical root of the propranolol-for-trauma research. (Separately, Eric Kandel's Nobel-winning memory work — on the molecular machinery of synaptic plasticity in Aplysia — is foundational to memory science but is a different line, not the noradrenergic-amygdala story.) (Established for emotional memory enhancement; clinical application contested — frontier section.)

05

How it shapes experience

Theory is cheap. Here's what the molecule actually feels like, in situations you've lived.

The near-miss. You're driving, a car swerves into your lane. Before you "decide" anything, your foot is off the gas, your eyes have locked on the threat, the world has gone slightly slow-motion and hyper-clear. That clarity — peripheral detail dropping away, the threat in razor focus — is phasic locus-coeruleus firing plus a sympathetic NE jolt to the heart, with epinephrine arriving a beat later to sustain it. The slow-motion feeling is partly your memory system over-encoding under NE: you're laying down so much detail per second that, on recall, it seems like more time passed.

The exam / the big call where you choke. You've prepared. You know it cold in the practice room. Then the stakes are real, your heart is pounding, and your mind goes blank — the prepared answer won't come. That's not weakness. That's NE crossing from the α2A range into the α1/β flood. Your prefrontal cortex — the part holding your knowledge in working memory — has been chemically taken offline and the brain handed to reflex. This is Arnsten's mechanism in the flesh. The "blank mind under pressure" is a predictable pharmacological event, not a character flaw.

The 3 a.m. wakeup. You jolt awake at 3 a.m., heart going, and immediately your mind generates a watertight case for why everything is falling apart. Part of this is a nocturnal cortisol/NE bump meeting a still-half-asleep prefrontal cortex. The vigilance system is online (NE scanning for threat) but the reasoning system that would contextualize and dismiss the threat is underpowered. The "everything is terrible" verdict is an arousal artifact. In the morning, same facts, NE balanced, prefrontal cortex back online — the catastrophe evaporates. The feeling lied because the chemical state, not the facts, wrote the script.

Flow vs. anxiety. Both flow and anxiety are elevated arousal. The difference is where on the inverted-U you sit and which way attention points. In flow, NE (with dopamine and acetylcholine) sits at the optimum — engaged, focused, time-distorted, effortless. In anxiety, NE has tipped past the peak — the same energy, now scattered, scanning, narrowing into threat. This is why a small reframe ("I'm excited" instead of "I'm nervous" — Alison Wood Brooks's "anxiety reappraisal" work, Journal of Experimental Psychology: General, 2014; the effect is real but modest and has been hard to replicate cleanly, so hold it loosely) can plausibly help: it doesn't lower the arousal, it changes how the same arousal is steered. The molecule's already there; the question is which side of the peak you ride it on.

The drowsy afternoon. Can't focus, eyes heavy, re-reading the same line. That's low tonic locus-coeruleus firing — not enough NE to hold the prefrontal signal above noise. This is the other side of the inverted-U, the under-aroused side, and it's exactly where stimulants and caffeine (which indirectly raises NE) move you back up the curve.

06

Where it's distorted / oversold

Now the honest cut. NE is real and well-understood, so the distortions here are subtler than crystal-shop stuff — they're mostly oversimplifications that get presented as settled science.

The Yerkes-Dodson curve is real, but it's been flattened into a slogan. The clean, symmetric inverted-U you see in pop-psychology and management slide decks comes from a 1908 mouse study about visual discrimination under electric shock, generalized far beyond what the data support. The honest position:

  • The phenomenon — performance peaks at intermediate arousal for hard tasks — is robust and confirmed many times over, especially for prefrontal-dependent cognition (Arnsten gives it a mechanism).
  • But the smooth bell curve is an idealization — and a retrofitted one. The 1908 paper drew no such curve and stated no "law"; the tidy inverted-U graphic and the very name "Yerkes-Dodson law" were applied by later authors (notably Hebb in the 1950s) reaching back to relabel the old data. Real performance curves are messy, the "optimal" point shifts with task type and individual, and "arousal" in the 1908 sense (shock intensity) is not cleanly the same variable as "norepinephrine level." Treating the curve as a precise law you can dial yourself to is overreach. Treat it as a shape, not a formula. (Phenomenon: established. Precise lawfulness: contested/oversold.)

"Adrenaline" used as a catch-all. Popular language calls everything adrenaline — "adrenaline junkie," "adrenaline rush." Most of the fast neural effects you're labeling adrenaline are actually norepinephrine. Adrenaline (epinephrine) is the slower, blood-borne broadcast. This isn't pedantry; it's the difference between a neurotransmitter and a hormone, and it changes how you'd intervene (a beta-blocker, for instance, blunts the peripheral adrenaline-driven symptoms — pounding heart, shaky hands — without sedating the brain).

"Low norepinephrine causes depression / ADHD is a norepinephrine deficiency." This is the catecholamine-deficiency framing, and it's the same trap as the serotonin "chemical imbalance" myth. The reality: NE dysregulation is involved in depression and ADHD, drugs that modulate NE help many people, but a simple "you have too little NE" model is not supported. ADHD is better understood as a problem of prefrontal signal-to-noise and network tuning (Arnsten's framing) than a literal fuel shortage. The drugs work by retuning the gain, not by "topping up a missing chemical." Stating it as a deficiency is myth dressed as mechanism. (Dysregulation: established. Simple deficiency: myth.)

"Stimulants give you focus by raising norepinephrine." Half-true and worth nailing. ADHD stimulants raise both dopamine and norepinephrine by acting on their transporters (methylphenidate mainly blocks reuptake; amphetamine both blocks reuptake and reverses the transporters to push the transmitters out). Crucially, in ADHD the therapeutic doses are low — they nudge you up toward the α2A "optimum" part of the curve. Take too much and you blow past the peak into the α1/β flood: jittery, anxious, worse focus, tunnel vision. This is why "more is better" is exactly wrong for these drugs, and why a dose that helps one person makes another anxious. The inverted-U governs the medication, not just the symptom. (Established.)

The "norepinephrine is the focus molecule, dopamine is the motivation molecule" clean split. Useful as a starting heuristic, false as a hard line. They're made on the same assembly line, co-released in places, and the locus coeruleus and dopamine systems are deeply interactive. Don't build a worldview on one-molecule-one-job. (Oversimplification.)

07

The debates & frontier

*Adaptive-gain theory: is the locus coeruleus an arousal system or a decision system? The Aston-Jones–Cohen theory (2005) reframed the whole field. The claim: the locus coeruleus regulates the exploration–exploitation tradeoff. Phasic mode (sharp bursts on task-relevant events, moderate tonic baseline) = exploitation — you're locked into the current task, focused, milking the known reward. High tonic mode (elevated baseline, weak phasic bursts) = exploration — restless, disengaging from the current task, scanning for something better. On this view, what feels like "getting distracted and restless" isn't a failure; it's the locus coeruleus shifting you from exploit to explore because the current task stopped paying off. The molecule isn't just "alertness" — it's the brain's commitment vs. search dial. This is the dominant current framework, and it's genuinely beautiful, but it's a theory*, well-supported but still being refined — not a closed case. (Contested/active.)

Locus coeruleus and Alzheimer's / aging. A striking and active frontier: the locus coeruleus is now thought to be one of the earliest sites of tau pathology in Alzheimer's disease — possibly affected decades before symptoms, before even the entorhinal cortex. Mara Mather and others argue that locus-coeruleus integrity may be a key factor in cognitive reserve — that keeping this system engaged (through challenging mental effort, which fires it) may help protect the aging brain. If it holds up, it reframes "use it or lose it" with a specific noradrenergic mechanism. (Active research, promising, not settled.)

Propranolol and traumatic memory. Because NE drives the consolidation of emotional memory (McGaugh), the beta-blocker propranolol has been tested to blunt the emotional charge of traumatic memories — given soon after trauma, or during therapeutic "reconsolidation" (reactivating a memory then dosing to weaken it). Results are mixed — some encouraging reconsolidation studies (Alain Brunet's work on PTSD), some failed prevention trials. It's a real, mechanistically-grounded line of research, not science fiction, but it is not an established, reliable treatment, and the ethics of memory-dampening are genuinely debated. (Contested.)

*Does NE cause arousal or report it? A deeper, less-settled question: is the locus coeruleus the driver of arousal state, or is it one node in a larger network (with acetylcholine, histamine, orexin/hypocretin, serotonin) where it's more of a coordinator than a king? The honest frontier answer: NE is necessary and central* to normal arousal regulation, but arousal is a distributed, multi-system property, and crowning any single transmitter "the arousal molecule" overstates it. (Active.)

The amygdala–prefrontal seesaw. Arnsten's framework — high NE strengthens amygdala/habit while weakening prefrontal control — is well-supported but its full dynamics (timing, individual differences, why some people are resilient to stress-impairment and others crumble) are still being worked out. The direction is established; the details are frontier. (Mixed.)

08

How to work with it

Practical, mechanism-honest. Not "raise your norepinephrine" — that's the wrong frame. The frame is: find your spot on the inverted-U for the task in front of you, and steer there.

  1. Match arousal to task difficulty — deliberately. The original 1908 finding still holds: harder, more novel, more cognitively-demanding tasks need a lower arousal level; routine, simple, physical tasks tolerate (and even benefit from) high arousal. So: for deep, complex thinking, you want calm-alert, not hyped. For a grind workout or a high-energy physical performance, crank it. The common mistake is using "psych yourself up" energy (great for a deadlift) before a delicate cognitive task (where it pushes you past the peak into the α1/β flood and you choke). Right tool, right curve.
  1. When you're past the peak (anxious, blanking, tunnel-visioned): drop arousal through the body, not the mind. You can't think your way down — your thinking apparatus is the thing that's offline. Long exhales (extended exhale activates the parasympathetic brake), a physiological sigh, cold on the face, slowing physically. You're physically pulling NE back from the α1/β range toward α2A so your prefrontal cortex comes back online. Then the prepared answer returns.
  1. When you're under the peak (drowsy, scattered, can't engage): raise arousal through the body too. Movement, brief intense exercise, cold exposure, sunlight, and yes caffeine (which indirectly raises NE) move you up the curve into focus range. A walk before hard work isn't avoidance — it's tuning the locus coeruleus into phasic/exploit mode.
  1. Reframe the arousal instead of fighting it. Brooks's anxiety-reappraisal finding: telling yourself "I'm excited" rather than "calm down" outperforms both. You're not lowering NE (futile in the moment); you're steering the same arousal toward approach instead of threat — the difference between flow and panic on the same energy.
  1. Use NE's memory hook on purpose. Because arousal stamps in memory, the things you learn while genuinely engaged (mild stakes, real interest) stick far better than the things you slog through bored. Don't study flat. Add real stakes, novelty, or emotional weight to what you want to remember — you're recruiting the amygdala-NE consolidation tag deliberately.
  1. Respect the dose curve if you're medicated. If you take stimulants or atomoxetine: more is not more. The therapeutic window is a spot on the inverted-U, not a ceiling. Overshooting trades focus for anxiety. Work with a prescriber to find the spot, not the maximum.
  1. Protect the off-switch — sleep, especially REM. The locus coeruleus goes near-silent in REM; that silence appears important for memory and emotional processing. Chronically elevated nighttime NE (stress, alcohol rebound, screens-and-cortisol) keeps the system from fully powering down. Guard the conditions that let the broadcast system go quiet.
09

How It Connects

This maps onto the Law of Vibration as a useful analogy, not a literal mechanism: brainwave bands and arousal states are measurable, but they are not "vibration" in the metaphysical sense. The Vibration deep dive made the case that your mental state is, non-metaphorically, a vibratory state (dominant brainwave band), that state is changeable through the body, and that state determines perception and recall. Norepinephrine is one of the literal molecular knobs that sets that vibratory state. When the locus coeruleus shifts its firing, it shifts your dominant arousal band — drowsy low-frequency to alert high-frequency — exactly the "raise/lower your vibration" claim, made concrete in a brainstem nucleus. The inverted-U is the Vibration law's warning that higher is not always better given precise teeth: past the optimum, the same "raised vibration" tips into the α1/β flood and degrades you. And the Vibration claim that state shapes what you perceive (the RAS filtering threat) is, mechanistically, NE-driven vigilance biasing the brain toward salient/threatening input — a fearful "frequency" literally surfaces more threat because high tonic NE has tuned the system to scan for it. The 3 a.m. catastrophe and the "change frequency before you trust the verdict" advice are the same phenomenon seen from two altitudes.

Related structures and concepts: dopamine (one enzymatic step away — the wanting molecule vs. the urgency molecule, made on the same line); epinephrine/adrenaline (NE's hormonal sibling — the blood-borne broadcast vs. the neural telegraph); the HPA axis and cortisol (the slower stress system NE's fast response hands off to); acetylcholine, orexin/hypocretin, histamine, serotonin (the other arousal-system transmitters NE coordinates with); the amygdala (NE's memory-tagging and threat partner); the prefrontal cortex (the structure NE tunes up at low dose and shuts down at high — the seat of the choke and the focus); flow states (the optimum of the curve, where NE + dopamine + acetylcholine align); the Law of Polarity (anxiety and flow as the same arousal at two points on one scale, moved by changing degree — exactly Polarity's claim); and the Law of Rhythm (the locus coeruleus's tonic baseline rising and falling across the day and the sleep-wake cycle — vibration over time).

The Compression

Norepinephrine is the gain knob, not the signal — it doesn't decide what you do, it decides how urgently and how sharply your whole brain runs, and there's an exact amount that makes you brilliant and a little more that makes you blank.

Your Practice
My Depth
My Notes
← Previous
Serotonin
Next →
Oxytocin